 |
 |
PackGene and Kudo Biotechnology offer a one-stop platform for GMP mRNA and LNP by providing plasmid production, mRNA synthesis, Lipid Nanoparticle(LNP) encapsulation, formulation development, IND filing assistance, fill and finish, and complete documentation. We prioritize regulatory compliance and provide a quality management system that is fully compliant with regulatory standards. We offer customized process development for DNA templates, mRNA drug substances, and drug products to optimize each project’s potential. Furthermore, our comprehensive analytical panel for plasmid, mRNA and LNP provides valuable insights that allow for customized in-process control, release testing, and stability studies. Our streamlined process ensures efficiency and reliability, while our regulatory-compliant QMS and comprehensive analytical approaches ensure superior quality that exceeds industry standards. With both PD and cGMP facilities in operation, we offer a seamless transition from development to manufacturing, delivering unparalleled expertise, professionalism, and convenience in mRNA and LNP production.
Excellent performance and track record
Our commitment to product quality has resulted in achieving a world-class standard that is comparable to the industry’s renowned CDMO products for mRNA and LNP. Our rigorous quality control processes and comprehensive analytical testing ensure that our products meet and exceed the highest global standards. Trust us to deliver outstanding results for your drug development project.
One Stop Shop
For all your mRNA manufacturing needs. Our streamlined process ensures ease in your CMC
Performance
Speed
Quality
Full compliance with global regulatory requirements
*Quality specifications are for a typical linear mRNA, 3-5 Kbp.
Plasmid cGMP Manufacturing Site
|
|
Read More
PackGene’s state-of-the-art GMP plasmid production site located in Guangzhou, China, and is dedicated to providing reliable, compliant, and scalable plasmid production services. With a team of ~40 staff members, including management staff members with over 15 years of experience and over 7 years of AAV and plasmid prep experience. The site and staff ensure that reliable materials are generated for the production of high-quality mRNA, and our team takes shifts to ensure continuous production without interruption.
The facility is equipped with fermenters ranging from 5L to 200L, enabling batch sizes of up to ~100g plasmid, with hundreds of lots produced yearly.
PackGene s plasmid production site has a 1,300 sqf PD room and a 11,000 sqf GMP room, ensuring compliance with regulatory standards. With its reliability, scalability, and compliance, the facility provides high-quality plasmid production services that exceed industry standards.
PackGene Biotech, Guangzhou, China
mRNA and LNP cGMP Manufacturing Site
|
|
Kudo Biotechnology, Shanghai, China
mRNA PD lab
- 5,500 sqf lab
- North American PD lab to efficiently support US/EU clients
Read More
Kudo Biotechnology has a 57,000 square feet facility in Minhang, Shanghai, designed and constructed in compliance with cGMP and global regulatory guidelines. Our facility accommodates 3 mRNA lines, 2 LNP bulk lines, and 1 drug product fill & finish line. Our production lines fulfill manufacturing needs for preclinical studies through Phase 2 clinical trials, and our facility architecture has the capacity to manufacture up to 40 million vials/year, accommodating scales necessary for Phase 3 trials and commercial manufacturing.
Kudo Biotechnology is a one-stop CDMO for customers worldwide, offering Process Development, Technology Transfer, cGMP manufacturing, Fill & finish, Testing & Release, and Supply Chain Management. Our facility is equipped with cutting-edge equipment customized for mRNA, to consistently achieve high product quality. Kudo’s deployment of Remote Terminal Units prevents cross-contamination, and allows for quick response to business and production changes to meet the dynamic needs of different customers and projects.
Kudo’s Manufacturing Sciences & Analytical Technology laboratories enable the development and transfer of manufacturing technologies between our facility and external partners. These laboratories can also produce non-GMP material for early-stage preclinical and toxicology studies.
Kudo Biotechnology, Boston, MA. USA
At PackGene and Kudo Biotechnology, we are committed to delivering the highest quality GMP mRNA production process. Our process starts with GMP plasmid DNA manufacturing, which includes the creation of an E. coli strain cell bank, fermentation, plasmid DNA purification, and QC release to ensure that the DNA is of the highest quality.
Next, we move on to mRNA transcription and purification, where we linearize the pDNA and perform in-vitro transcription, capping, dsRNA removal, bulk purification, and QC release to ensure that the mRNA is pure and free from contaminants.
Our comprehensive analytical panel allows for customized in-process control, release testing, and stability studies for plasmid, mRNA, and LNP. This enables us to tailor our approach to meet the specific needs of your project and ensure that the final product is of the highest quality.
Analysis of plasmid
- Restriction Pattern
- Sequence
- Purity
- Content
- Residual Protein
- Residual DNA
- Residual RNA
- Bioburden
- Endotoxin
Analysis of mRNA
- pH
- Content
- Sequence
- Purity
- mRNA Integrity
- Capping Efficiency
- Poly A Tail Length
- Residual pDNA
- Residual Protein
- Residual NTPs
- dsRNA Content
- Residual Solvents
- Bioburden
- Endotoxin
Analysis of LNP
- pH
- Osmolality
- Encapsulation %
- mRNA Integrity
- Lipid Content
- LNP Site
- LNP Polydispersity
- Residual Solvent
- Potency
- Sterility
- Endotoxin
- Subvisible Particle
- Extractable Volume
With our advanced analytical tools, we monitor every step of the production process to identify any potential issues early. This allows us to take corrective action quickly and efficiently when necessary. Our commitment to using the latest analytical techniques means that you can have confidence in the accuracy and reliability of our testing methods.
| Activities | M1 | M2 | M3 | M4 | M5 | M6 | M7 | |||||||
| MCB Generation | ||||||||||||||
| MCB Characterization | ||||||||||||||
| WCB Generation | ||||||||||||||
| WCB Characterization | ||||||||||||||
| pDNA upstream process development | ||||||||||||||
| pDNA downstream process development | ||||||||||||||
| Set-up of analytical methods for pDNA | ||||||||||||||
| RNA platform process development | ||||||||||||||
| Set-up of analytical methods for RNA | ||||||||||||||
| LNP-DP platform process development | ||||||||||||||
| Set-up of analytical methods for LNP-DP |  |
|||||||||||||
| Engineering (non-GMP) batch & release | ||||||||||||||
| Analytical methods Validation | ||||||||||||||
| GMP batch |  |
|||||||||||||
| GMP batch release | ||||||||||||||
| Total excl. tax | ||||||||||||||
non-GMP batch, 4 months
GMP batch, 6.5 months
Platform Technology Timeline: At PackGene and Kudo Biotechnology, we pride ourselves on our industrial-leading timeline of 6.5 months from PCB to GMP release. This streamlined process makes us highly competitive in the market, allowing us to provide you with the highest quality GMP mRNA and LNP production in a timely and efficient manner. Trust us to deliver exceptional results, while still meeting all regulatory requirements and maintaining the highest quality standards. With our efficient timeline and commitment to excellence, we are confident that we can meet and exceed your expectations for your next project.
Quality Management System
Our Quality Management System is designed to ensure that every aspect of the product quality realization process is carefully monitored and controlled. This includes personnel, facilities and equipment, environment, materials, manufacturing, QC, and product release. We also employ validation and qualification protocols to ensure that our products meet the highest standards of quality. In addition, our quality assurance program includes change control, deviation handling, complaint handling, quality management review, recall procedures, internal audits, and corrective and preventive action planning, all guided by our quality risk management framework. Finally, all of our processes are thoroughly documented to ensure transparency and traceability, providing you with the confidence that your product is of the highest quality.
Our commitment to quality is at the heart of everything we do. Our Quality Management System is a comprehensive framework that ensures every step of our process is carefully planned, executed, and monitored to meet the highest standards.
Comprehensive documentation is essential to ensure regulatory compliance and product quality. At our facility, we provide extensive documentation covering all aspects of the drug development process, including project management, operation procedures, and quality control. This documentation is meticulously maintained throughout the entire lifecycle of the drug, from R&D, to clinical trials, and commercialization.
Project Document
- Enquiry Assessment
- Manufacture Summary
- Packaging Summary
- Delivery Summary
- Agreement and Contract
Operation Document
- SOPs
- Goods Receiving Record
- Work Order
- Batch Record
- Shipping Request
- Distribution Record
- Logbook
- Environment Monitor
Quality Document
- Specification
- Material and Product Test
- CoA
- Batch Record Review and Release
- Stability Data
- Validation Report
- Supplier Qualification
